178 related articles for article (PubMed ID: 32490633)
1. The utility of synovial fluid levels of ADAMTS9 and ADAMTS4 in predicting treatment responses to intraarticular steroid injections in patients with knee osteoarthritis.
Özler K
Turk J Med Sci; 2020 Aug; 50(5):1330-1336. PubMed ID: 32490633
[TBL] [Abstract][Full Text] [Related]
2. The role of increased synovial fluid A disintegrin and metalloproteinase with thrombospondin motifs4 and serglycin levels in osteoarthritis.
Özler K
Ir J Med Sci; 2019 Aug; 188(3):867-872. PubMed ID: 30536194
[TBL] [Abstract][Full Text] [Related]
3. Relationship between increased serum & synovial fluid decorin levels & knee osteoarthritis.
Ozler K
Indian J Med Res; 2021 Apr; 153(4):453-458. PubMed ID: 34380791
[TBL] [Abstract][Full Text] [Related]
4. Synovial Fluid HMGB-1 Levels are Associated with Osteoarthritis Severity.
Ke X; Jin G; Yang Y; Cao X; Fang R; Feng X; Lei B
Clin Lab; 2015; 61(7):809-18. PubMed ID: 26299081
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Hylan versus Hyaluronic Acid in the Treatment of Knee Osteoarthritis.
Dai WL; Lin ZM; Guo DH; Shi ZJ; Wang J
J Knee Surg; 2019 Mar; 32(3):259-268. PubMed ID: 29618143
[TBL] [Abstract][Full Text] [Related]
6. Effects of different hyaluronic acid products on synovial fluid NO levels in knee osteoarthritis.
Karatay S; Kiziltunc A; Yildirim K; Karanfil RC; Senel K
Clin Rheumatol; 2005 Sep; 24(5):497-501. PubMed ID: 15906109
[TBL] [Abstract][Full Text] [Related]
7. Profiling of inflammatory mediators in the synovial fluid related to pain in knee osteoarthritis.
Li L; Li Z; Li Y; Hu X; Zhang Y; Fan P
BMC Musculoskelet Disord; 2020 Feb; 21(1):99. PubMed ID: 32059658
[TBL] [Abstract][Full Text] [Related]
8. The role of ADAMTS4 and ADAMTS9 in cardiovascular disease in premature ovarian insufficiency and idiopathic hypogonadotropic hypogonadism.
Ozler S; Isci Bostanci E; Oztas E; Kuru Pekcan M; Gumus Guler B; Yilmaz N
J Endocrinol Invest; 2018 Dec; 41(12):1477-1483. PubMed ID: 30187439
[TBL] [Abstract][Full Text] [Related]
9. Altered microRNA expression profile in synovial fluid from patients with knee osteoarthritis with treatment of hyaluronic acid.
Xu JF; Zhang SJ; Zhao C; Qiu BS; Gu HF; Hong JF; Cao L; Chen Y; Xia B; Bi Q; Wang YP
Mol Diagn Ther; 2015 Oct; 19(5):299-308. PubMed ID: 26232909
[TBL] [Abstract][Full Text] [Related]
10. Plasma and synovial fluid autotaxin correlate with severity in knee osteoarthritis.
Mabey T; Taleongpong P; Udomsinprasert W; Jirathanathornnukul N; Honsawek S
Clin Chim Acta; 2015 Apr; 444():72-7. PubMed ID: 25659292
[TBL] [Abstract][Full Text] [Related]
11. Lorecivivint, a Novel Intraarticular CDC-like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial.
Yazici Y; McAlindon TE; Gibofsky A; Lane NE; Clauw D; Jones M; Bergfeld J; Swearingen CJ; DiFrancesco A; Simsek I; Tambiah J; Hochberg MC
Arthritis Rheumatol; 2020 Oct; 72(10):1694-1706. PubMed ID: 32432388
[TBL] [Abstract][Full Text] [Related]
12. Effects of different hyaluronic acid products on synovial fluid levels of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in knee osteoarthritis.
Karatay S; Kiziltunc A; Yildirim K; Karanfil RC; Senel K
Ann Clin Lab Sci; 2004; 34(3):330-5. PubMed ID: 15487709
[TBL] [Abstract][Full Text] [Related]
13. The Minimal Clinically Important Difference (MCID) for the WOMAC and Factors Related to Achievement of the MCID After Medial Opening Wedge High Tibial Osteotomy for Knee Osteoarthritis.
Kim MS; Koh IJ; Choi KY; Sung YG; Park DC; Lee HJ; In Y
Am J Sports Med; 2021 Jul; 49(9):2406-2415. PubMed ID: 34115533
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic Acid Versus Platelet-Rich Plasma: A Prospective, Double-Blind Randomized Controlled Trial Comparing Clinical Outcomes and Effects on Intra-articular Biology for the Treatment of Knee Osteoarthritis.
Cole BJ; Karas V; Hussey K; Pilz K; Fortier LA
Am J Sports Med; 2017 Feb; 45(2):339-346. PubMed ID: 28146403
[TBL] [Abstract][Full Text] [Related]
15. Serum and knee synovial fluid matrix metalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late-stage osteoarthritis.
Özler K; Aktaş E; Atay Ç; Yılmaz B; Arıkan M; Güngör Ş
Acta Orthop Traumatol Turc; 2016; 50(3):356-61. PubMed ID: 27130394
[TBL] [Abstract][Full Text] [Related]
16. A prospective, randomized, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee.
Petrella RJ; Petrella M
J Rheumatol; 2006 May; 33(5):951-6. PubMed ID: 16652426
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial.
Raynauld JP; Buckland-Wright C; Ward R; Choquette D; Haraoui B; Martel-Pelletier J; Uthman I; Khy V; Tremblay JL; Bertrand C; Pelletier JP
Arthritis Rheum; 2003 Feb; 48(2):370-7. PubMed ID: 12571845
[TBL] [Abstract][Full Text] [Related]
18. Soluble TNF receptors are produced at sites of inflammation and are inversely associated with self-reported symptoms (WOMAC) in knee osteoarthritis.
Simão AP; Almeida TM; Mendonça VA; Santos SA; Gomes WF; Coimbra CC; Lacerda AC
Rheumatol Int; 2014 Dec; 34(12):1759-63. PubMed ID: 24748490
[TBL] [Abstract][Full Text] [Related]
19. Synovial Fluid Eotaxin-1 Levels May Reflect Disease Progression in Primary Knee Osteoarthritis Among Elderly Han Chinese: A Cross-Sectional Study.
Li B; Zhang YL; Yu SY
Cartilage; 2019 Oct; 10(4):408-416. PubMed ID: 29562767
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory characteristics on ultrasound predict poorer longterm response to intraarticular corticosteroid injections in knee osteoarthritis.
Chao J; Wu C; Sun B; Hose MK; Quan A; Hughes TH; Boyle D; Kalunian KC
J Rheumatol; 2010 Mar; 37(3):650-5. PubMed ID: 20080918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
